Glomerular barrier dysfunction in glomerulosclerosis-resistant Milan rats with experimental diabetes: The role of renal haemodynamics

Journal of Pathology

Volumn 213, Issue 2, 2007, Pages 210-218

  Pugliese, G ^a   Ricci, C ^a   Iacobini, C ^a   Menini, S ^a   Fioretto, P ^b   Ferrandi, M ^c   Giardino, L A ^d   Armelloni, S ^d   Mattinzoli, D ^d   Rastaldi, M P ^d   Pugliese, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Prassis Sigma Tau Research Institute   (Italy)

^d Fondazione D'Amico per la Ricerca sulle Malattie Renali   (Italy)

Author keywords

Experimental diabetes; Glomerulosclerosis; Hypertension; Nephrin; Podocyte; Proteinuria; Renal haemodynamics; Synaptopodin

Indexed keywords

NEPHRIN; SERUM ALBUMIN; SYNAPTOPODIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; GLOMERULAR DYSFUNCTION; GLOMERULOSCLEROSIS; INFLAMMATORY CELL; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION;

AGING; ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN A, GLYCOSYLATED; KIDNEY GLOMERULUS; MALE; PODOCYTES; PROTEINURIA; RATS; RATS, MUTANT STRAINS; RENAL ARTERY; SERUM ALBUMIN, BOVINE; SPECIES SPECIFICITY; WEIGHT GAIN;

EID: 35348988767     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2226     Document Type: Article

References (40)

1. Estacio RO, Schrier RW. Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression. Adv Intern Med 2001;46:359-408.
2. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989;38:1077-1081.
3. Ziyadeh FN, Goldfarb S. The renal tubulointerstitium in diabetes mellitus. Kidney Int 1991;39:464-475.
4. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-1155.
5. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005;54:1626-1634.
6. Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006;55:225-233.
7. Petermann AT, Pippin J, Durvasula R, Pichler R, Hiromura K, Monkawa T, et al. Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 2005;67:157-166.
8. Di Mario U, Pugliese G. 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 2001;44:674-692.
9. O'Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 1997;17:93-100.
10. Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001;44:1957- 1972.
11. Brandis A, Bianchi G, Reale E, Helmchen U, Kuhn K. Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest 1987;55:234-243.
12. Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, Garcia R, et al. Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A 1994;91:3999-4003.
13. Ferrandi M, Tripodi G, Salardi S, Florio M, Modica R, Barassi P, et al. Renal Na,K-ATPase in genetic hypertension. Hypertension 1996;28:1018-1025.
14. Menini S, Ricci C, Iacobini C, Bianchi G, Pugliese G, Pesce C. Glomerular number and size in Milan hypertensive and normotensive rats: their relationship to susceptibility and resistance to hypertension and renal disease. J Hypertens 2004;22:2185-2192.
15. Pugliese G, Pricci F, Barsotti P, Iacobini C, Ricci C, Oddi G, et al. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: possible permissive role of hemodynamics. Kidney Int 2005;67:1440-1452.
16. Ricci C, Iacobini C, Oddi G, Amadio L, Menini S, Rastaldi MP, et al. Role of TGF-β/GLUT1 axis in susceptibility vs. resistance to diabetic glomerulopathy in the Milan rat model. Nephrol Dial Transplant 2006;21:1514-1524.
17. Kriz W, Hosser H, Hahnel B, Gretz N, Provoost AP. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 1998;13:2781-2798.
18. Gray JE, Van Zwieten MJ, Hollander CF. Early light microscopic changes of chronic progressive nephrosis in several strains of aging laboratory rats. J Gerontol 1982;37:142-150.
19. Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ, et al. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 1997;51:230-243.
20. Hostetter TH. Human renal response to a meat meal. Am J Physiol (Renal Fluid Electrolyte Physiol) 1986;250:F613-F618.
21. Castellino P, Coda B, DeFronzo RA. Effect of amino acid infusion on renal hemodynamics in humans. Am J Physiol (Renal Fluid Electrolyte Physiol) 1986;251:F132-F140.
22. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003;52:1031-1035.
23. Rastaldi MP, Armelloni S, Berra S, Li M, Pesaresi M, Poczewski H, et al. Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a. Am J Pathol 2003;163:889-899.
24. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307.
25. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131-2147.
26. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001;59:2104-2113.
27. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348.
28. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002;51:3083-3089.
29. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999;42:1341-1344.
30. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005;67:404-419.
31. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
32. Wernerson A, Duner F, Pettersson E, Widholm SM, Berg U, Ruotsalainen V, et al. Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003;18:70-76.
33. Branten AJ, van den Born J, Jansen JL, Assmann KJ, Wetzels JF. Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int 2001;59:693-701.
34. Good KS, O'Brien K, Schulman G, Kerjaschki D, Fogo AB. Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of 'no change disease'. Am J Kidney Dis 2004;43:933-938.
35. Alvarez V, Quiroz Y, Nava M, Pons H, Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol (Renal Physiol) 2002;283:F1132-F1141.
36. Weening JJ, Van Guidener C, Daha MR, Klar N, van der Wal A, Prins FA. The pathophysiology of protein-overload proteinuria. Am J Pathol 1987;129:64-73.
37. Sánchez-Lozada LG, Tapia E, Johnson RJ, Rodriguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int 2003;64(Suppl 86):S9-S14.
38. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002;13:3005-3015.
39. Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, et al. Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 2005;16:1703-1710.
40. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003;23:4917- 4928.